Three-drug cocktail shows potential to boost CAR-T cancer therapy

Preclinical research findings from the University of North Carolina Lineberger Comprehensive Cancer Center have identified a cocktail of three different drugs that can be used to generate more robust immune system CAR-Ts (chimeric antigen receptor-T cells) to fight cancer. This finding may have a significant impact on improving the production of CAR-T cells for clinical use.
Read More

Next-generation COVID-19 vaccine presents promising results in mice

Studies conducted in mice have shown that the COVID-19 vaccine being developed by researchers at the University of São Paulo’s Medical School (FM-USP) in Brazil is safe and efficacious. The vaccine triggered a satisfactory immune response against the pathogen in the mice and protected them from infection. An article describing the results is published in the journal Scientific Reports.
Read More

Discovery of Semliki Forest virus’s brain entry route opens new avenues for tumor treatment

In a recent study, researchers from Uppsala University have shown that the Semliki Forest virus enters the central nervous system by first entering the cerebrospinal fluid and then binding to a specific cell type before penetrating deeper into the brain. This finding could potentially be used to develop the Semliki Forest virus as an agent for treating brain cancer. The study has been published in Nature Communications.
Read More
Top